Efficacy and safety of the emedastine patch, a novel transdermal drug delivery system for allergic rhinitis: Phase III, multicenter, randomized, double-blinded, placebo-controlled, parallel-group comparative study in patients with seasonal allergic rhinit
Keywords: امدادستین; Emedastine; Randomized controlled trial; Seasonal allergic rhinitis; Sustained action; Transdermal drug delivery system; FAS; full analysis set; CI; confidence interval; Ig; immunoglobulin; LOCF; last observation carried forward; LSM; least squares mean;